Last deal

$9M

Amount

Series A

Stage

07.12.2020

Date

6

all rounds

$9.1M

Total amount

General

About Company
Kenota Health develops next-generation rapid point-of-care system for allergy testing in humans.

Industry

Sector :

Subsector :

Keywords :

Also Known As

ExVivo Labs

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company manufactures diagnostic tools that collect a small blood sample and insert it into streamlined equipment to determine allergen sensitization in a few minutes. The tools offer a cheaper alternative to allergy testing using a thorough non-invasive technology, and print patient test results on the spot, enabling physicians to receive better diagnostic information and improve patient outcomes. Kenota Health's mission is to make allergy testing safe, simple, and certain.
Contacts